Linear DaptoMycin(883991-21-7)
- Name: Linear DaptoMycin
- Synonyms:Daptomycin Impurity 3;Daptomycin Impurity 18;Daptomycin Linear Impurity;Benzenebutanoic acid, N-(1-oxodecyl)-L-tryptophyl-D-asparaginyl-L-α-aspartyl-L-threonylglycyl-L-ornithyl-L-α-aspartyl-D-alanyl-L-α-aspartylglycyl-D-seryl-(3R)-3-methyl-L-α-glutamyl-α,2-diamino-γ-oxo-, (αS)-;(2S,5S,8R,14S,17R,20S,23S,29S,32S)-32-((R)-4-Amino-2-((S)-2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-2-(2-(2-aminophenyl)-2-oxoethyl)-23-(3-aminopropyl)-14,20-bis(carboxymethyl)-5-((S)-1-carboxypropan-2-yl)-29-((R)-1-hydroxyethyl)-8-(hydr;Linear Daptomycin;Daptomycin Lactone Hydrolysate
- Molecular Formula:C72H103N17O27
- Molecular Weight:1638.69
- CAS Registry Number:883991-21-7
- EINECS:
- Melting Point:2074.8±65.0 °C(Predicted)
- Water Solubility:
Other Product
- 883949-22-2/(1Z)-N'-Hydroxy-2-thiomorpholin-4-ylethanimidamide
- 883950-09-2/4-Pyridinecarboxylic acid, 2-chloro-6-(2,2,2-trifluoroethoxy)-
- 883953-85-3/8-methoxy-2-methyl-3-phenylchromeno[2,3-d]pyrimidine-4,5-dione
- 88395-42-0/1-Benzopyrylium, 3-[(4-O-acetyl-β-D-glucopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, chloride (9CI)
- 883956-29-4/3-butyl-2-(furan-2-yl)chromeno[2,3-d]pyrimidine-4,5-dione
- 883959-62-4/N-[3-(4-methoxyphenyl)-1-methyl-4-oxoquinolin-2-yl]acetamide
- 883959-66-8/N-[3-(4-methoxyphenyl)-1-methyl-4-oxoquinolin-2-yl]propanamide
- 883959-83-9/3-methyl-N-(8-methyl-4-oxo-3-phenylchromen-2-yl)butanamide
- 883962-00-3/N-[1-ethyl-3-(4-methoxyphenyl)-4-oxoquinolin-2-yl]acetamide
- 883963-33-5/7-(3,4-dimethoxyphenyl)-5-methylbenzimidazo[2',1':6,1]pyrimido[4,5-b]quinolin-14(5H)-one
- 883964-01-0/2-methoxy-3-(4-phenylpiperazin-1-yl)quinoxaline
- 883964-47-4/N-[1-methyl-3-(4-methylphenyl)-4-oxoquinolin-2-yl]acetamide
- 883975-39-1/Carbamic acid, [2-[[[4-[(4-chlorophenyl)methoxy]-3-methoxyphenyl]methyl](2-thienylcarbonyl)amino]ethyl]-, 1,1-dimethylethyl ester (9CI)
- 883985-17-9/Benzeneacetamide, 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-N-(3-methoxyphenyl)-
- 883985-75-9/Benzeneacetamide, 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-N-[5-(dimethylamino)-2-pyridinyl]-
- 883986-27-4/Benzeneacetamide, 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-N-(1-ethyl-1H-pyrazol-3-yl)-
- 883986-32-1/Benzeneacetamide, 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-N-(1-methyl-1H-pyrazol-4-yl)-
- 883986-33-2/Benzeneacetamide, 4-[(6,7-dimethoxy-4-quinazolinyl)oxy]-N-(1-ethyl-1H-pyrazol-4-yl)-
- 883987-85-7/Carbamic acid, (6-amino-3-pyridinyl)methyl-, 1,1-dimethylethyl ester (9CI)
- 883991-21-7/Linear DaptoMycin
- 883997-73-7/4H-Indazol-4-one, 1-[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-1,5,6,7-tetrahydro-
- 883997-74-8/1H-Indazol-4-ol, 1-[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-4,5,6,7-tetrahydro-
- 884001-35-8/AKOS BB-3635
- 884006-55-7/CarbaMic acid, [(1R,3R)-3-[[(Methylsulfonyl)oxy]Methyl]cyclopentyl]-, 1,1-diMethylethyl ester (9CI)
- 884006-65-9/rac-(1R,3S)-3-aminocyclopentane-1-carbonitrile
- 884006-67-1/tert-butyl- N-3-(cyanomethyl)cyclopentyl]carbamate, cis
- 884007-71-0/Cyclopentanamine, 3-(1H-1,2,4-triazol-1-ylmethyl)-, (1R,3S)-rel-
- 884009-99-8/Ac-Val-Tyr-Lys-NH2
- 884010-48-4/4-(pentafluoroethyl)benzene-1-sulfonyl chloride
- 884033-66-3/1H-Benzimidazole-2-propanoic acid, 6-fluoro-α-[(2-naphthalenylcarbonyl)amino]-, (αR)-
